CYLTEZO (adalimumab-adbm) Patient Assistance Program
Don’t let the cost of biologic therapy disrupt your treatment. We help eligible patients access Cyltezo (adalimumab-adbm) — an FDA-approved interchangeable biosimilar to Humira — for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing — Every Route Below Is Free To Use Directly
- Paperwork, Documentation & Doctor-Coordination Handled For You
- Comprehensive Support: From Application To Entire Journey
- Annual Re-certification And Refills Management
- Humira-Switch Guidance — Interchangeable Means Your Pharmacist Can Substitute It
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Cyltezo (Adalimumab-adbm) Is An FDA-Approved Interchangeable Biosimilar To Humira — Same Active Molecule Class, Same Indications (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s, Ulcerative Colitis, Psoriasis, And More), Held To The FDA’s Highest Biosimilar Standard.
- The Price Story Is Dramatic: While Branded Cyltezo Retails Near Humira’s ~$7,000/Month, Boehringer Ingelheim’s Unbranded Adalimumab-adbm Sells For As Little As $550 Per Month Cash Through An Exclusive GoodRx Program — 92% Off Humira’s List — At Walgreens, Costco, And Other Major Chains.
- Commercially Insured Patients Pay As Little As $0 Per Prescription Through The Cyltezo Copay Program, And The BI Cares Foundation Provides Free Medication To Uninsured And Underinsured Patients — Including Some Medicare Enrollees.
- Ten Adalimumab Biosimilars Now Compete, But Your PBM’s Formulary — Not The Lowest Price — Usually Decides Which One Your Insurance Prefers. Knowing Your Plan’s Pick Before The Pharmacy Counter Is The Whole Game.
What is Cyltezo Prescription Assistance Program?
Cyltezo assistance is really three doors. First, for anyone paying cash: Boehringer Ingelheim’s unbranded adalimumab-adbm — identical medicine, plainer label — sells for as little as $550 per two-pen monthly supply through an exclusive GoodRx arrangement, honored at Walgreens, Costco, Meijer, and Sam’s Club regardless of insurance status. Second, for the commercially insured: the Cyltezo Copay Program (1-833-295-8396) takes eligible patients to as little as $0 per prescription. Third, for the uninsured and underinsured: the BI Cares Patient Assistance Program (1-800-556-8317) provides free medication in 90-day shipments, with Medicare Part D patients considered case by case and annual re-enrollment. All three are free to use directly. The complication is upstream: with ten adalimumab biosimilars competing, your insurer’s formulary may prefer a different one entirely, and being prescribed the “wrong” biosimilar for your plan generates denials that look like coverage failures but are really product-selection problems. For a flat $69.95 per month, our Patient Advocates match product to plan, run the paperwork, and keep every program current.
Pharmacy Price Comparison
- Without assistance, Cyltezo costs roughly $6,600–$7,900 per month at retail pharmacies. Discount coupons offer some relief, but they don't come close to what a Patient Assistance Program provides — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$7,800.00 | Save ~$7,730/mo |
| CVS Pharmacy | ~$7,900.00 | Save ~$7,830/mo |
| Walmart | ~$7,200.00 | Save ~$7,130/mo |
| Costco | ~$6,900.00 | Save ~$6,830/mo |
| Kroger | ~$7,100.00 | Save ~$7,030/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Cyltezo Prescription Program ?
The Patient Assistance Program is free to apply for and provides Cyltezo at little or no medication cost if approved. But the process involves detailed applications, prescriber coordination, specialty pharmacy logistics, and ongoing renewal management — particularly important for a refrigerated biologic injectable. Our $69.95/month service covers full advocacy: applications, doctor coordination, cold-chain delivery management, refill management, and annual re-enrollment — so you focus on your health, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Abraxane:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $6,600–$7,900 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Between the three routes, nearly everyone qualifies for something. For free medication through the BI Cares Foundation specifically, you will generally qualify if the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Cyltezo assistance:
- You are a U.S. citizen or legal resident
- You Have A Valid Cyltezo (Or Adalimumab-adbm) Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured — Medicare Part D Patients Are Considered Case By Case
- You Meet The Foundation’s Financial Criteria For Your Household Size
Understanding Cyltezo:
Cyltezo (adalimumab-adbm) is a biosimilar to Humira — a TNF-blocker biologic held to the FDA’s “interchangeable” standard, the designation that allows pharmacists to substitute it for Humira the way they substitute generics for brand pills.
How Cyltezo Works:
Like Humira, adalimumab-adbm is a monoclonal antibody that binds and neutralizes TNF-alpha, the inflammatory signaling protein that drives rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and related conditions. Biosimilar approval required demonstrating no clinically meaningful differences from Humira — and the interchangeable designation required additional switching studies showing patients can alternate between the two without loss of effect or added risk.
Form and Use:
Self-injected subcutaneously via prefilled pen or syringe, typically every other week (weekly in some conditions), matching Humira’s dosing. Two versions exist with identical medicine inside: branded Cyltezo (priced near Humira) and unbranded “adalimumab-adbm” (the low-price version behind the $550 cash program). Which label your prescription specifies, and which your plan’s formulary prefers, determines your price far more than anything clinical — which is why the paperwork strategy is the treatment-access strategy.
The Biosimilar Market:
Ten adalimumab biosimilars now compete against Humira, with low-price tiers running 80–92% below Humira’s list. But PBM formularies — not sticker prices — decide what your insurance covers: some plans prefer CVS’s private-label version, others Sandoz’s, others still brand Humira with rebates. The practical rule: never assume the biosimilar you’ve heard of is the one your plan wants. We check before your prescriber writes the script.
Warnings:
As a TNF blocker, Cyltezo carries the class boxed warnings: serious infections including tuberculosis (test before starting), and malignancies including lymphoma. Avoid live vaccines during treatment; report persistent fevers, cough, or unusual bruising promptly. Tell your prescriber about any history of heart failure, hepatitis B, or demyelinating disease. The safety profile mirrors Humira’s — that equivalence is what biosimilar approval establishes
FAQ (Frequently Asked Questions)
How Much Does Cyltezo Cost Without Insurance?
The unbranded version (adalimumab-adbm) sells for as little as $550 per monthly two-pen supply through the exclusive GoodRx program at major chains — 92% below Humira’s ~$7,000 list. Income-eligible uninsured patients can get it entirely free through BI Cares. Our $69.95 monthly fee covers routing you to the cheaper of the two.
Is Cyltezo Really The Same As Humira?
It’s an FDA-designated interchangeable biosimilar — the highest standard, requiring switching studies on top of standard biosimilar evidence. Clinically, regulators treat substitution as routine. If you’re doing well on Humira and your plan pushes a switch, the data supports it; if you have concerns, that’s a conversation with your rheumatologist or GI we can help frame.
What’s The Difference Between Branded Cyltezo And Unbranded Adalimumab-adbm?
The label and the price — the medicine is identical, made by the same company. Branded Cyltezo prices near Humira; the unbranded version anchors the $550 cash program. Pharmacies treat them as different products, so the prescription and the program must match — a detail we handle.
Does Medicare Cover Cyltezo?
Adalimumab products are Part D drugs, plan-dependent by formulary, with the $2,100 annual cap (2026) as backstop. The copay program excludes Medicare, but BI Cares considers Part D patients case by case — and sometimes the $550 cash route beats a high Part D tier outright. We run all three numbers.
My Insurance Prefers A Different Biosimilar — Now What?
Usually: take the plan’s preferred product, which will have the lowest copay — the ten biosimilars are all held to the same FDA standard. Fighting for a specific biosimilar rarely wins and rarely matters clinically. Where we push back is when the plan prefers brand Humira at a worse tier than a biosimilar would cost you.
Take Control of Your Medication Costs
The Humira affordability crisis effectively ended when interchangeable biosimilars arrived — but only for patients who know the routes: $550 cash, $0 copay, or free through BI Cares. Most still don’t. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.